X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11) 11
hypertension (10) 10
humans (9) 9
peripheral vascular disease (9) 9
animals (8) 8
blood-pressure (7) 7
male (7) 7
proteinuria (7) 7
blood pressure - drug effects (6) 6
mechanisms (6) 6
hypertension - chemically induced (5) 5
rats (5) 5
rats, inbred wky (5) 5
vascular endothelial growth factor (5) 5
angiogenesis inhibition (4) 4
endothelin-1 (4) 4
endothelin-1 - metabolism (4) 4
female (4) 4
hypertension - physiopathology (4) 4
indoles - pharmacology (4) 4
nitric-oxide (4) 4
physics, applied (4) 4
pyrroles - pharmacology (4) 4
angiogenesis inhibitors - pharmacology (3) 3
carcinoma, renal cell - drug therapy (3) 3
endothelial growth-factor (3) 3
expression (3) 3
hypertension - drug therapy (3) 3
hypertension - metabolism (3) 3
indoles - adverse effects (3) 3
kidney neoplasms - drug therapy (3) 3
middle aged (3) 3
molecular-beam epitaxy (3) 3
nitric oxide - metabolism (3) 3
oxidative stress (3) 3
photoluminescence (3) 3
physics, condensed matter (3) 3
pyrroles - adverse effects (3) 3
sunitinib (3) 3
vascular endothelial growth factor a - antagonists & inhibitors (3) 3
vascular endothelial growth factor a - metabolism (3) 3
78.55.cr (2) 2
activation (2) 2
aged (2) 2
angiogenesis (2) 2
antineoplastic agents - adverse effects (2) 2
bradykinin - pharmacology (2) 2
chemical-vapor-deposition (2) 2
complications and side effects (2) 2
coronary circulation - drug effects (2) 2
cubic gan (2) 2
dose-response relationship, drug (2) 2
endocrinology & metabolism (2) 2
endothelin 1 (2) 2
epitaxy (2) 2
gaas (2) 2
gastrointestinal stromal tumors - drug therapy (2) 2
growth (2) 2
health aspects (2) 2
indoles - therapeutic use (2) 2
indoles - toxicity (2) 2
inhibitor sunitinib (2) 2
kidney - drug effects (2) 2
kidney - metabolism (2) 2
kidney diseases - chemically induced (2) 2
kidney diseases - metabolism (2) 2
nadph oxidase (2) 2
optical-properties (2) 2
phase epitaxy (2) 2
preeclampsia (2) 2
preeclampsia-like syndrome (2) 2
pyrroles - therapeutic use (2) 2
pyrroles - toxicity (2) 2
quantum dots (2) 2
rarefaction (2) 2
rat (2) 2
receptor (2) 2
receptors, vascular endothelial growth factor - antagonists & inhibitors (2) 2
receptors, vascular endothelial growth factor - metabolism (2) 2
renal-cell carcinoma (2) 2
research (2) 2
signal transduction - drug effects (2) 2
tyrosine kinase inhibitors (2) 2
vascular endothelial growth factor a (2) 2
vascular endothelial growth factor a - blood (2) 2
vegf (2) 2
71.35.–y (1) 1
78.47.+p (1) 1
78.67.de (1) 1
81.07.ta (1) 1
abridged index medicus (1) 1
absorption (1) 1
absorptionskante (1) 1
acute kidney injury - chemically induced (1) 1
acute kidney injury - drug therapy (1) 1
acute kidney injury - physiopathology (1) 1
acute renal injury (1) 1
albuminuria (1) 1
alignment (1) 1
amlodipine - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hypertension, ISSN 0194-911X, 10/2010, Volume 56, Issue 4, pp. 675 - 681
Journal Article
Nederlands tijdschrift voor geneeskunde, ISSN 0028-2162, 2015, Volume 160, p. A9937
Resistant hypertension is defined as blood pressure above the target level despite treatment with 3 classes of antihypertensive drugs, including a diuretic. A... 
Blood Pressure | Humans | Diet, Sodium-Restricted | Diuretics - therapeutic use | Hypertension - drug therapy | Hypertension - therapy | Antihypertensive Agents - therapeutic use | Blood Pressure Determination
Journal Article
Journal Article
Journal Article
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 10/2011, Volume 96, Issue 10, pp. 3087 - 3094
Journal Article
Journal of the American Society of Hypertension, ISSN 1933-1711, 11/2018, Volume 12, Issue 11, pp. e1 - e7
Angiogenesis inhibition with bevacizumab, a monoclonal antibody against vascular endothelial growth factor A (VEGF-A), is an anticancer treatment associated... 
angiogenesis inhibition | nephrinuria | Albuminuria | INHIBITION | THERAPY | VEGF | SUNITINIB | PROTEINURIA | PERIPHERAL VASCULAR DISEASE | PREECLAMPSIA-LIKE SYNDROME | HYPERTENSION
Journal Article
Journal of Hypertension, ISSN 0263-6352, 12/2009, Volume 27, Issue 12, pp. 2297 - 2309
Inhibition of angiogenesis with humanized monoclonal antibodies to vascular endothelial growth factor (VEGF) or with tyrosine kinase inhibitors targeting VEGF... 
Hypertension | Vvascular endothelial growth factor | Renal disease | Angiogenesis inhibition | Cardiac disease | Proteinuria | SUNITINIB TREATMENT | DEPENDENT RELAXATION | proteinuria | COHERENCE TOMOGRAPHY FINDINGS | cardiac disease | BEVACIZUMAB AVASTIN(R) | TYROSINE-KINASE INHIBITOR | renal disease | BLOOD-PRESSURE | INTRAVITREAL INJECTION | angiogenesis inhibition | PHASE-I TRIAL | vascular endothelial growth factor | PERIPHERAL VASCULAR DISEASE | hypertension | ENDOTHELIAL GROWTH-FACTOR | MOLECULAR-MECHANISMS | Kidney Diseases - physiopathology | Humans | Antibodies, Monoclonal - adverse effects | Endothelium, Vascular - drug effects | Vascular Endothelial Growth Factor A - metabolism | Protein Kinase Inhibitors - adverse effects | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | Hypertension - physiopathology | Hypertension - metabolism | Gene Expression Regulation - drug effects | Receptors, Vascular Endothelial Growth Factor - metabolism | Signal Transduction - drug effects | Endothelium, Vascular - metabolism | Hypertension - chemically induced | Kidney Diseases - chemically induced | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Angiogenesis Inhibitors - adverse effects | Kidney Diseases - metabolism | Index Medicus
Journal Article
Hypertension, ISSN 0194-911X, 08/2011, Volume 58, Issue 2, pp. 295 - 302
Journal Article
Nederlands Tijdschrift voor Geneeskunde, ISSN 0028-2162, 04/2011, Volume 155, Issue 16, pp. 742 - 747
Journal Article
European Journal of Hospital Pharmacy, ISSN 2047-9956, 2012, Volume 19, Issue 3, pp. 327 - 329
Angiogenesis inhibition with humanised monoclonal antibodies to vascular endothelial growth factor (VEGF) or with VEGF receptor tyrosine kinase inhibitors... 
ANGIOGENESIS | BIOMARKER | NITRIC-OXIDE | RESISTANCE | PHARMACOLOGY & PHARMACY | MECHANISMS | INHIBITOR SUNITINIB | ENDOTHELIN-1 | CANCER
Journal Article
Physica E: Low-dimensional Systems and Nanostructures, ISSN 1386-9477, 2004, Volume 21, Issue 2, pp. 285 - 289
Decay dynamics for single InGaN quantum dots are presented using time-resolved photoluminescence. The recombination is shown to be characterized by a single... 
InGaN | Single quantum dots | Time-resolved luminescence | time-resolved luminescence | PHYSICS, CONDENSED MATTER | single quantum dots | PHOTOLUMINESCENCE
Journal Article
Physica E: Low-dimensional Systems and Nanostructures, ISSN 1386-9477, 2004, Volume 21, Issue 2, pp. 546 - 550
A novel method for the growth of InGaN quantum dots (QDs) by metal-organic vapour phase epitaxy (MOVPE) is described. A thin InGaN epilayer is grown on a GaN... 
MOVPE growth | InGaN photoluminescence | Quantum dots | quantum dots | PHYSICS, CONDENSED MATTER | THRESHOLD | PHOTOLUMINESCENCE | GAN
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.